Literature DB >> 9512545

Signal-dependent degradation of IkappaBalpha is mediated by an inducible destruction box that can be transferred to NF-kappaB, bcl-3 or p53.

F G Wulczyn1, D Krappmann, C Scheidereit.   

Abstract

Activation of the transcription factor NF-kappaB in response to a variety of stimuli is governed by the signal-induced proteolytic degradation of NF-kappaB inhibitor proteins, the IkappaBs. We have investigated the sequence requirements for signal-induced IkappaBalpha phosphorylation and proteolysis by generating chimeric proteins containing discrete sub-regions of IkappaBalpha fused to the IkappaBalpha homologue Bcl-3, the transcription factor NF-kappaB1/p50 and the tumour suppressor protein p53. Using this approach we show that the N-terminal signal response domain (SRD) of IkappaBalpha directs their signal-dependent phosphorylation and degradation when transferred to heterologous proteins. The C-terminal PEST sequence from IkappaBalpha was not essential for induced proteolysis of the chimeric proteins. A deletion analysis conducted on the SRD identified a 25 amino acid sub-domain of IkappaBalpha that is necessary and sufficient for the degradative response in vivo and for recognition by TNFalpha-dependent IkappaBalpha kinase in vitro . The results obtained should prove instrumental in the further characterization of IkappaB-specific kinases, as well as the E2 and E3 enzymes responsible for IkappaBalpha ubiquitination. Furthermore, they suggest a novel strategy for generating conditional mutants, by targetting heterologous proteins for transient elimination by the IkappaBalpha pathway.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9512545      PMCID: PMC147453          DOI: 10.1093/nar/26.7.1724

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  49 in total

1.  The proteolysis of mitotic cyclins in mammalian cells persists from the end of mitosis until the onset of S phase.

Authors:  M Brandeis; T Hunt
Journal:  EMBO J       Date:  1996-10-01       Impact factor: 11.598

Review 2.  Ubiquitin-dependent protein degradation.

Authors:  M Hochstrasser
Journal:  Annu Rev Genet       Date:  1996       Impact factor: 16.830

3.  Reduced ubiquitin-dependent degradation of c-Jun after phosphorylation by MAP kinases.

Authors:  A M Musti; M Treier; D Bohmann
Journal:  Science       Date:  1997-01-17       Impact factor: 47.728

4.  A gradient of cytoplasmic Cactus degradation establishes the nuclear localization gradient of the dorsal morphogen in Drosophila.

Authors:  A Bergmann; D Stein; R Geisler; S Hagenmaier; B Schmid; N Fernandez; B Schnell; C Nüsslein-Volhard
Journal:  Mech Dev       Date:  1996-11       Impact factor: 1.882

5.  The carboxy-terminus of I kappaB alpha determines susceptibility to degradation by the catalytic core of the proteasome.

Authors:  M Kroll; M Conconi; M J Desterro; A Marin; D Thomas; B Friguet; R T Hay; J L Virelizier; F Arenzana-Seisdedos; M S Rodriguez
Journal:  Oncogene       Date:  1997-10-09       Impact factor: 9.867

6.  The signal response of IkappaB alpha is regulated by transferable N- and C-terminal domains.

Authors:  K Brown; G Franzoso; L Baldi; L Carlson; L Mills; Y C Lin; S Gerstberger; U Siebenlist
Journal:  Mol Cell Biol       Date:  1997-06       Impact factor: 4.272

7.  Activation of the IkappaB alpha kinase complex by MEKK1, a kinase of the JNK pathway.

Authors:  F S Lee; J Hagler; Z J Chen; T Maniatis
Journal:  Cell       Date:  1997-01-24       Impact factor: 41.582

8.  Different mechanisms control signal-induced degradation and basal turnover of the NF-kappaB inhibitor IkappaB alpha in vivo.

Authors:  D Krappmann; F G Wulczyn; C Scheidereit
Journal:  EMBO J       Date:  1996-12-02       Impact factor: 11.598

Review 9.  The NF-kappa B/Rel and I kappa B gene families: mediators of immune response and inflammation.

Authors:  F G Wulczyn; D Krappmann; C Scheidereit
Journal:  J Mol Med (Berl)       Date:  1996-12       Impact factor: 4.599

10.  The ankyrin repeats but not the PEST-like sequences are required for signal-dependent degradation of IkappaBalpha.

Authors:  T Aoki; Y Sano; T Yamamoto; J I Inoue
Journal:  Oncogene       Date:  1996-03-07       Impact factor: 9.867

View more
  7 in total

1.  Regulation of constitutive p50/c-Rel activity via proteasome inhibitor-resistant IkappaBalpha degradation in B cells.

Authors:  Shelby O'Connor; Stuart D Shumway; Ian J Amanna; Colleen E Hayes; Shigeki Miyamoto
Journal:  Mol Cell Biol       Date:  2004-06       Impact factor: 4.272

2.  The SCFbeta-TRCP-ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in IkappaBalpha and beta-catenin and stimulates IkappaBalpha ubiquitination in vitro.

Authors:  J T Winston; P Strack; P Beer-Romero; C Y Chu; S J Elledge; J W Harper
Journal:  Genes Dev       Date:  1999-02-01       Impact factor: 11.361

3.  Regions of IkappaBalpha that are critical for its inhibition of NF-kappaB.DNA interaction fold upon binding to NF-kappaB.

Authors:  Stephanie M E Truhlar; Justin W Torpey; Elizabeth A Komives
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-05       Impact factor: 11.205

4.  A three-part signal governs differential processing of Gli1 and Gli3 proteins by the proteasome.

Authors:  Erin K Schrader; Kristine G Harstad; Robert A Holmgren; Andreas Matouschek
Journal:  J Biol Chem       Date:  2011-09-15       Impact factor: 5.157

5.  Effects of IkappaBalpha and its mutants on NF-kappaB and p53 signaling pathways.

Authors:  Xian Li; Da Xing; Ju Wang; De-Bin Zhu; Lan Zhang; Xiao-Jia Chen; Fen-Yong Sun; An Hong
Journal:  World J Gastroenterol       Date:  2006-11-07       Impact factor: 5.742

6.  Hypoxia regulates iNOS expression in human normal peritoneal and adhesion fibroblasts through nuclear factor kappa B activation mechanism.

Authors:  Zhong L Jiang; Nicole M Fletcher; Michael P Diamond; Husam M Abu-Soud; Ghassan M Saed
Journal:  Fertil Steril       Date:  2008-02-20       Impact factor: 7.329

Review 7.  NF-kappaB regulation: the nuclear response.

Authors:  Arun K Mankan; Matthew W Lawless; Steven G Gray; Dermot Kelleher; Ross McManus
Journal:  J Cell Mol Med       Date:  2009-04       Impact factor: 5.310

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.